Publicacions en què col·labora amb Deisy Barrios (39)

2024

  1. Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 141-149

  2. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

2023

  1. La especialidad de Neumología: antecedentes, desarrollo asistencial y científico, perspectivas futuras

    RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 8, Núm. 2, pp. 17-24

  2. The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism

    American Heart Journal, Vol. 257, pp. 62-68

2022

  1. Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

    The European respiratory journal, Vol. 59, Núm. 2

2021

  1. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

2020

  1. Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi

    European Respiratory Journal

  2. Implications of Abnormal Troponin Levels With Normal Right Ventricular Function in Normotensive Patients With Acute Pulmonary Embolism

    Clinical and Applied Thrombosis/Hemostasis, Vol. 26

2019

  1. Accuracy and Interobserver Reliability of the Simplified Pulmonary Embolism Severity Index Versus the Hestia Criteria for Patients With Pulmonary Embolism

    Academic Emergency Medicine, Vol. 26, Núm. 4, pp. 394-401

  2. Meta-Analysis of Prevalence and Short-Term Prognosis of Hemodynamically Unstable Patients With Symptomatic Acute Pulmonary Embolism

    American Journal of Cardiology, Vol. 123, Núm. 4, pp. 684-689

  3. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease

    Clinical Cardiology, Vol. 42, Núm. 3, pp. 346-351

2018

  1. A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism

    Thrombosis Research, Vol. 165, pp. 107-111

  2. Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism

    Thrombosis Research, Vol. 164, pp. 40-44

  3. Clinical gestalt versus prognostic scores for prognostication of patients with acute symptomatic pulmonary embolism

    Medicina Clinica, Vol. 151, Núm. 4, pp. 136-140

  4. Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study

    Thrombosis Research, Vol. 162, pp. 1-6

  5. Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis

    Thorax, Vol. 73, Núm. 5, pp. 464-471

  6. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism

    International Journal of Cardiology, Vol. 269, pp. 327-333

  7. Higher Adherence to Treatment with Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin because of Side Effects in Cancer-Associated Venous Thromboembolism

    HemaSphere, Vol. 2, Núm. 1

  8. Management appropriateness and outcomes of patients with acute pulmonary embolism

    European Respiratory Journal, Vol. 51, Núm. 5

  9. Performance of Early Prognostic Assessment Independently Predicts the Outcomes in Patients with Acute Pulmonary Embolism

    Thrombosis and Haemostasis